| Literature DB >> 22606715 |
.
Abstract
This final rule with comment period revises the Medicare Advantage (MA) program (Part C) regulations and prescription drug benefit program (Part D) regulations to implement new statutory requirements; strengthen beneficiary protections; exclude plan participants that perform poorly; improve program efficiencies; and clarify program requirements. It also responds to public comments regarding the long-term care facility conditions of participation pertaining to pharmacy services.Entities:
Mesh:
Year: 2012 PMID: 22606715
Source DB: PubMed Journal: Fed Regist ISSN: 0097-6326